Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (507) Colon Cancer Screening
...CenterWatch: Clinical Trials in Category (507) Colon Cancer Screening Colon Cancer Screening State • Kentucky Kentucky Lexington : University of Kentucky Chandler Medical Center New! Patients Undergoing ...
View Page

2.  Study Posting (2205) Trial #156842, Ulcerative Colitis, Chicago, IL
...purpose of this research is to investigate the bacteria that lives in the intestines and colon of healthy individuals compared to persons experiencing IBD. Humans have bacteria that live and grow in the colon. These bacteria serve important purposes in the colon. They help to digest food and keep ...
View Page

3.  Study Posting (2205) Trial #156841, Crohn's Disease, Chicago, IL
...purpose of this research is to investigate the bacteria that lives in the intestines and colon of healthy individuals compared to persons experiencing IBD. Humans have bacteria that live and grow in the colon. These bacteria serve important purposes in the colon. They help to digest food and keep ...
View Page

4.  Study Posting (4519) Trial #102728, Colorectal Cancer, Montevideo, Uruguay
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

5.  Study Posting (4519) Trial #105424, Colorectal Cancer, Istanbul, Turkey
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

6.  Study Posting (4519) Trial #147815, Colorectal Cancer, Sion, Switzerland
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

7.  Study Posting (4519) Trial #105062, Colorectal Cancer, Neuchatel, Switzerland
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

8.  Study Posting (4519) Trial #105196, Colorectal Cancer, Chur, Switzerland
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

9.  Study Posting (4519) Trial #105039, Colorectal Cancer, Bellinzona, Switzerland
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

10.  Study Posting (4519) Trial #147279, Colorectal Cancer, Basel, Switzerland
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

11.  Study Posting (4519) Trial #100457, Colorectal Cancer, Stockholm, Sweden
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

12.  Study Posting (4519) Trial #101785, Colorectal Cancer, Oerebro, Sweden
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

13.  Study Posting (4519) Trial #101638, Colorectal Cancer, Lund, Sweden
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

14.  Study Posting (4519) Trial #100121, Colorectal Cancer, Linkoeping, Sweden
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

15.  Study Posting (4519) Trial #104295, Colorectal Cancer, Goeteborg, Sweden
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

16.  Study Posting (4519) Trial #98028, Colorectal Cancer, Valencia, Spain
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

17.  Study Posting (4519) Trial #100982, Colorectal Cancer, Toledo, Spain
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

18.  Study Posting (4519) Trial #103806, Colorectal Cancer, Terrassa, Spain
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

19.  Study Posting (4519) Trial #104075, Colorectal Cancer, Sevilla, Spain
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page

20.  Study Posting (4519) Trial #97984, Colorectal Cancer, Santander, Spain
...Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Status: No longer recruiting Protocol Number: MO18024 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific Title: First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial) Brief Summary: This expanded access study will ...
View Page